An Educational Webinar Series on Coordinated Care Organizations (CCOs)

About the Webinar Series

This free three-part series will help health care providers (HCPs) and practice managers understand coordinated care organizations (CCOs), and evaluate and respond to their management of anti-VEGF treatments. As CCOs take on responsibility for the cost of care and drugs from payers, some are instituting management that can affect anti-VEGF treatments. Part 1 of the webinar series distinguishes between different types of CCOs and explains how their origin shapes their management focus. Part 2 introduces the management tools that CCOs use to manage anti-VEGF treatments. Part 3 Provides strategies to improve access and ensure HCP therapeutic choice vis-à-vis CCO management. HCPs can react on how their current practices are aligned with CCO policies and processes. Each webinar will be approximately 60 minutes including Q&A.

Percipient Welcomes Ken LaPensee as Vice President

Percipient Welcomes Ken LaPensee as Vice President

SOMERVILLE (February 10, 2015) – Percipient announced today that it has appointed Ken LaPensee as Vice President. Ken will play a leadership role and enhance our recognized excellence in Market Access strategy for biopharmaceutical and other life science companies. Percipient is playing an increasing role in value-based positioning of new therapies and our clients are seeking greater alignment across global markets in doing so. In this context, Ken’s arrival also expands our Health Economics and global Evidence Strategy capabilities, enabling us to deliver a higher level of strategic support to our HEOR and Medical Affairs clients.

Ken has 35 years’ experience in managed care and the pharmaceutical industry concentrating on health economics and market access strategy for the US and European markets. Most recently, Ken has developed and supported value arguments for treatments for infections, stroke and depression. Ken has expertise in generating supportive clinical and economic evidence using clinical trials, economic models, real world data, and systematic reviews as required by payers in the US and Europe. While in health insurance, Ken directed actuarial research and assessed healthcare technologies for medical directors. As the leader of Cambridge Pharma Consultancy’s US health care strategy practice, Ken advised clients on integrating therapies into the wide variety of payment and delivery systems in the US and European markets. Ken holds a Ph.D. in Social Science and Health Services from the University of Connecticut and a MPH in Epidemiology from the New Jersey School of Public Health.

About Percipient
Percipient is a strategic consulting firm that helps pharmaceutical, biotech and medical device manufacturers successfully navigate market access challenges. We assist clients in various stages of the product life cycle, providing support from strategy formulation to its implementation in areas such as access and reimbursement, pricing and contracting, patient assistance, product positioning, evidence gap analysis, and health reform navigation. Visit Percipient at

Contact Us
Tel: 908.801.7400